Botulinum Toxin Type A in Diabetic Peripheral Neuropathy

Status Completed

Clinical Trial Summary

Background: Diabetes mellitus is commonly complicated by diabetic peripheral neuropathy. Due to common side effects and poor tolerance to medication, poor adherence to medication is common in diabetic peripheral neuropathy. Botulinum toxin A intradermal injection has proved efficacy in cases of diabetic peripheral neuropathy however there is a need to compare its effect with other lines of treatment. The aim of the study was to compare botulinum toxin type a verses conventional oral treatment as a second line treatment of painful diabetic peripheral neuropathy. This study was conducted as a comparative study on 30 patients with type 2 diabetes mellitus proved by nerve conduction study on carbamazepine. Patients were divided randomly into 3 groups. First group was add on duloxetine, second was add on gabapentin and the third group was injected intradermal with botulinum toxin A.

Clinical Trial Description

This study is a comparative study on 30 patients with type 2 diabetes mellitus proved by nerve conduction study on carbamazepine. Patients were divided randomly into 3 groups. First group was add on duloxetine, second was add on gabapentin and the third group was injected intradermal with Botulinum toxin A. Base line Assessment before treatment and follow up assessment as performed The treatment options were explained to the patients and the choice of Botulinum toxin A Intradermal injection was the patient own decision based on inability to be tolerate or adhere to oral treatment. ;

Study Design

Related Conditions & MeSH terms

Diabetic Neuropathies

Clinical Trial Details

NCT number	NCT05296759
Study type	Interventional
Source	Alexandria University
Contact
Status	Completed
Phase	Phase 4
Start date	February 1, 2021
Completion date	March 8, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05683106` - Effects of Customized Silicone Digital Orthoses in People With Diabetic Neuropathy	N/A
Withdrawn	`NCT04106050` - Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic Polyneuropathy	Phase 1
Completed	`NCT04088929` - The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy	Phase 2
Completed	`NCT01939366` - Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves	Phase 2
Withdrawn	`NCT00815932` - The Effect of Transcranial Direct Current Stimulation (t-DCS) On the P300 Component of Event-Related Potentials in Patients With Chronic Neuropathic Pain Due To CRPS or Diabetic Neuropathy	N/A
Completed	`NCT01926522` - Technological Rehabilitation of Distal Sensorimotor Polyneuropathy in Diabetic Patients	N/A
Not yet recruiting	`NCT01180608` - Functional Imaging of the Therapeutic Effect of Pregabalin in Treatment for Neuropathic Pain	N/A
Completed	`NCT00380913` - Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Diabetic Peripheral Neuropathy	Phase 4
Completed	`NCT00760955` - Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy	Phase 2
Terminated	`NCT00756041` - Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy	Phase 2
Completed	`NCT05255497` - The Effect of Sensorial Biodex Balance Balance System Exercises in Diabetic Neuropathy	N/A
Completed	`NCT06061237` - Effects of Aerobic Thai Dance in Patient With Diabetic Peripheral Neuropathy	N/A
Terminated	`NCT02915263` - The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes	Phase 2
Enrolling by invitation	`NCT05043636` - Diabetic Neuropathy Screening Study 1.1 + Substudy 1.2-1.3-1.4
Completed	`NCT06373809` - Placenta Derived Stem Cells for Treating of Chronic Ulcers and Neuropathy	Early Phase 1
Completed	`NCT05968131` - Comparative Effects of Proprioceptive Training and Routine Physical Therapy on Diabetic Peripheral Neuropathy	N/A
Completed	`NCT00282685` - Safety and Feasibility Study of Autologous Progenitor Cell Transplantation in Diabetic Neuropathy	Phase 1
Completed	`NCT00135109` - Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy	Phase 3
Completed	`NCT06292962` - Evaluating the Impact of Vagus Nerve Stimulation on Diabetic Peripheral Neuropathic Pain	N/A
Completed	`NCT05058807` - Effects of Whole Body Vibration in Diabetic Peripheral Neuropathy .	N/A